OSBPL9 Antibody (C-Terminus)
Rabbit Polyclonal Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| WB, IHC-P |
---|---|
Primary Accession | Q96SU4 |
Other Accession | 114883 |
Reactivity | Human, Mouse, Rat |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | IgG |
Calculated MW | 83185 Da |
Dilution | IHC-P (7.5 µg/ml), WB (1:500 - 1:3000), |
Gene ID | 114883 |
---|---|
Other Names | OSBPL9, ORP-9, ORP9, OSBP-related protein 9, OSBP4 |
Target/Specificity | Human, mouse, rat OSBPL9 |
Reconstitution & Storage | PBS, pH 7, 1% BSA, 20% Glycerol, 0.01% Thimerosal. Aliquot and freeze at -20° C. Avoid freeze-thaw cycles. |
Precautions | OSBPL9 Antibody (C-Terminus) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | OSBPL9 |
---|---|
Synonyms | ORP9, OSBP4 |
Cellular Location | Late endosome membrane. Golgi apparatus, trans-Golgi network membrane. Note=Localizes at the Golgi- late endosome interface |
Tissue Location | Widely expressed.. |
Volume | 50 µl |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
References
Jaworski C.J.,et al.Genomics 78:185-196(2001).
Hao D.C.,et al.Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
Ota T.,et al.Nat. Genet. 36:40-45(2004).
Ebert L.,et al.Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
Gregory S.G.,et al.Nature 441:315-321(2006).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.